Andere Kunden interessierten sich auch für
![Transdermal Drug Delivery of Raloxifene hydrochloride]( "Transdermal Drug Delivery of Raloxifene hydrochloride")
Transdermal Drug Delivery of Raloxifene hydrochloride44,99 €![Osmotic Drug Delivery System for a Poorly Soluble Drug]( "Osmotic Drug Delivery System for a Poorly Soluble Drug")
Osmotic Drug Delivery System for a Poorly Soluble Drug51,99 €![Formulation and Characterization of Ranitidine Hydrochloride]( "Formulation and Characterization of Ranitidine Hydrochloride")
Formulation and Characterization of Ranitidine Hydrochloride38,99 €![Study on Impurity Profiling of Flavoxate Hydrochloride]( "Study on Impurity Profiling of Flavoxate Hydrochloride")
Study on Impurity Profiling of Flavoxate Hydrochloride32,99 €![Formulation Of Fast Dissolving Tablets Of Phenylephrine Hydrochloride]( "Formulation Of Fast Dissolving Tablets Of Phenylephrine Hydrochloride")
Formulation Of Fast Dissolving Tablets Of Phenylephrine Hydrochloride38,99 €![Sustained Release Tablet of Itopride Hydrochloride]( "Sustained Release Tablet of Itopride Hydrochloride")
Sustained Release Tablet of Itopride Hydrochloride38,99 €![Design & Developement of Floating Tablet of Tolperisone Hydrochloride]( "Design & Developement of Floating Tablet of Tolperisone Hydrochloride")
Design & Developement of Floating Tablet of Tolperisone Hydrochloride44,99 €
The objective of this study is to develop controlled porosity osmotic pump tablet of Verapamil Hydrochloride, which is an antihypertensive candidate, using Polyethylene glycol (PEG) 400 as pore former in Cellulose acetate semipermeable membrane and Mannitol as a osmotic agent which release drug for extended period of time (24 h) and drug release of optimized formulation is independent of pH and agitation speed with zero order release.